A new service has launched, providing healthcare comms agencies with a one-stop-shop that supports them from the seed of an idea to success, removing some of the major risks of going it alo
While there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue to affect patients for some time.
The UK's Healthcare Communications Association (HCA) and Medical Journalists’ Association have launched a new best practice guide on approaching health journalists with a media story.
GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).